LILRB2 and central nervous system cancer: Moreover, PAX3 expression demonstrates significant positive correlations with multiple immune checkpoints, particularly PDCD1, SIGLEC7, and LILRB2, underscoring its involvement in immune regulation within the glioma microenvironment (Figure 7I).